Sponsor:
McGill University
Code:
NCT02296307
Conditions
Ovarian Neoplasms
Eligibility Criteria
Sex: Female
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Blood test: CA-125 biomarker
Second Test: Transvaginal Ultrasound
Follow-up phone call
Brief summary:
Conditions
Ovarian Neoplasms
Study ID
NCT02296307
Start date
Jan, 2012
Status verified date
May, 2024
Completion date
Jan, 2026
Anticipated
Primary completion date
Jan, 2025
Anticipated
Eligibility Criteria
Sex: Female
Age: 45+
Healthy Volunteers: Not accepted
Enrollment
13600 participants
Anticipated
Arms
DOvEE Participants
Interventions
Blood test: CA-125 biomarker
Second Test: Transvaginal Ultrasound
Follow-up phone call
Primary outcome measure
Central contacts
Locations
McGill University Health Centre, Royal Victoria Hospital
Recruiting
Montreal, Quebec, Canada, H4A 3J1
Contacts
Principal Investigator:
Lucy Gilbert, MD,MSc,FRCOG
Queen Elizabeth Health Centre
Recruiting
Montreal, Quebec, Canada, H4A 3L6
Principal Investigator:
Lucy Gilbert, MD,MSc,FRCOG
Sponsor
McGill University
Last update posted
May 2, 2024
Last verified
May, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by McGill University on 2024-05-02.